BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pang K, Lee J, Kim J, Park J, Park Y, Hong E, An H, Ooshima A, Son M, Park KS, Cho JH, Lee C, Song YS, Yang KM, Kim SJ. Degradation of DRAK1 by CUL3/SPOP E3 Ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells. Cell Death Dis 2022;13:169. [PMID: 35194034 DOI: 10.1038/s41419-022-04619-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Luo B, Lu Y, Chen Y. Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions. J Med Chem 2023;66:1112-36. [PMID: 36645394 DOI: 10.1021/acs.jmedchem.2c01606] [Reference Citation Analysis]
2 Yang X, Zhu Q. SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications. Genes 2022;13:2051. [DOI: 10.3390/genes13112051] [Reference Citation Analysis]
3 Zhai F, Wang J, Yang W, Ye M, Jin X. The E3 Ligases in Cervical Cancer and Endometrial Cancer. Cancers 2022;14:5354. [DOI: 10.3390/cancers14215354] [Reference Citation Analysis]
4 Vunjak M, Schwartz I, Cantoran García A, Mastrovito M, Hinterndorfer M, de Almeida M, Budroni V, Wang J, Froussios K, Jude J, Decker T, Zuber J, Versteeg GA. SPOP targets the immune transcription factor IRF1 for proteasomal degradation.. [DOI: 10.1101/2022.10.10.511567] [Reference Citation Analysis]
5 Wu J, Wu Y, Guo Q, Chen S, Wang S, Wu X, Zhu J, Ju X. SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization. J Transl Med 2022;20:384. [PMID: 36042498 DOI: 10.1186/s12967-022-03574-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang LB, Chen LJ, Wang Q, Xie XL. Silencing the Tlr4 Gene Alleviates Methamphetamine-Induced Hepatotoxicity by Inhibiting Lipopolysaccharide-Mediated Inflammation in Mice. Int J Mol Sci 2022;23:6810. [PMID: 35743253 DOI: 10.3390/ijms23126810] [Reference Citation Analysis]